ramkumarss's Updates (66)
-
-
HIV Diagnostics Market size was valued at USD 3.3 billion in 2022, growing at a CAGR of 9.8% during the forecast period 2023-2029. Acquired immune deficiency syndrome (AIDS) is a retroviral infectious disease caused by human immunodeficiency virus (HIV). HIV attacks the body immune system ideally CD4 cells (T cells), which helps the immune system to fight infections. HIV spreads through body fluids i.e. blood donation and imparting needles to somebody who is HIV infected, and sexual... -
-
-
Congestive Heart Failure Treatment market size was valued at USD 19.5 billion in 2022. It is expected to reach a value of USD 31.72 billion by 2029, growing with a CAGR of 7.2% from 2023-29. Congestive heart failure is a chronic and progressive condition that affects the pumping capacity of heart muscles and also referred as “heart failureâ€. Congestive heart failure can refer to the stage in which fluid builds up around the heart and causes it to pump... -
-
Uveitis Treatment Market size was valued at 581 million in 2021 and is expected to reach 857 million by 2028, at a CAGR of 5.7% during the forecast period 2022 to 2028. Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the uveitis. For instance, Aurinia Pharmaceuticals Inc. developing Luvenia, a calcineurin inhibitor for the treatment of... -
-
Infectious Disease Therapeutics Market size valued USD 128.4 billion in 2022 and expected to reach USD 175.32 billion by 2029, at a CAGR of 4.7% during the forecast period 2023-2029. Infectious diseases are caused by organisms, such as bacteria, virus, fungi or parasites. Many organisms live in our body but few of them cause diseases. These infectious diseases are transmitted from one individual to other either by direct or indirect contact. The drugs used for infectious diseases are... -
-
https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market Cancer Biomarker Testing Market was valued at USD 10.42 billion in 2022 and is anticipated to grow at USD 20.59 billion by 2029 recording a CAGR of 15.4% during the forecast period 2023-2029. The cancer biomarker test market is driven by rising prevalence of cancer... [more]
0 following
Copyright 2019 © P-tweets Refunds